Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.40 |
| ▸ | CA9 | Q16790 | 7/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.37 |
| ▸ | ABCC1 | P33527 | 4/20 | 0.37 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL866320 | 1.00 | CA12 (0.40) | CA12CA9CA1CA2CA4 | |
| SCHEMBL5019478 | 0.96 | CA12 (0.39) | CA12CA9CA1CA2CA4 | |
| SCHEMBL10195646 | 0.95 | MAOB (0.41) | CA12CA9CA1CA2CA4 | |
| SCHEMBL14019149 | 0.95 | CA12 (0.39) | CA12CA9CA1CA2CA4 | |
| SCHEMBL679261 | 0.94 | CA12 (0.43) | CA12CA9CA1CA2CA4 | |
| SCHEMBL679803 | 0.90 | ALOX5 (0.41) | CA12CA9CA1CA2CA4 | |
| SCHEMBL867176 | 0.90 | ALOX5 (0.41) | CA12CA9CA1CA2CA4 | |
| SCHEMBL865841 | 0.86 | ABCG2 (0.39) | CA12CA9CA1CA2CA4 | |
| SCHEMBL865842 | 0.86 | ABCG2 (0.39) | CA12CA9CA1CA2CA4 | |
| SCHEMBL864566 | 0.85 | CA12 (0.38) | CA12CA9CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| EP-1966119-B1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2016-10-19 | — | — | EP | disclosed |
| US-8557922-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2013-10-15 | — | — | US | disclosed |
| US-20130004679-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2013-01-03 | — | — | US | disclosed |
| US-8329823-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2012-12-11 | — | — | US | disclosed |
| US-8173749-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2012-05-08 | — | — | US | disclosed |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2012-03-29 | — | — | US | disclosed |
| EP-2308827-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-13 | — | — | EP | disclosed |
| EP-2308826-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-13 | — | — | EP | disclosed |
| EP-2305632-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-06 | — | — | EP | disclosed |
| EP-2305631-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-06 | — | — | EP | disclosed |
| US-20110065859-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2011-03-17 | — | — | US | disclosed |
| EP-2144951-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | Rolic AG (CH) | 2010-01-20 | — | — | EP | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| WO-2008135131-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2008-11-13 | — | — | WO | disclosed |
| EP-1966119-A1 | PHOTOCROSSLINKABLE MATERIALS | Rolic AG (CH) | 2008-09-10 | — | — | EP | disclosed |
| EP-1860094-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-11-28 | — | — | EP | disclosed |
| WO-2007071091-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2007-06-28 | — | — | WO | disclosed |
| EP-1801097-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293888-A1 | Photocrosslinkable Materials | DDC, PARG, ALAD | CA12 1753/4885CA9 1200/4885CA1 705/4885 |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | DDC, PARG, ALAD | CA12 1753/4885CA9 1200/4885CA1 705/4885 |
| US-20130004679-A1 | PHOTOCROSSLINKABLE MATERIALS | DDC, PARG, ALAD | CA12 1753/4885CA9 1200/4885CA1 705/4885 |
| US-20110065859-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | PARG, PARN, PUF60 | CA12 744/4885CA9 330/4885CA1 233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.